{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T06:07:05Z","timestamp":1786774025485,"version":"build-2736575974"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate adrenomedullin mRNA levels in the peripheral blood mononuclear cells (PBMCs) of patients with dermatomyositis (DM) as well as their correlation with the severity of interstitial lung disease (ILD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 41 DM patients and seven immune-mediated necrotizing myopathy (IMNM) patients were recruited, in addition to 21 healthy controls (HCs). The adrenomedullin mRNA levels in PBMCs were measured <jats:italic>via<\/jats:italic> quantitative reverse-transcription real-time polymerase chain reaction (qRT-PCR). The associations between adrenomedullin expression levels and major clinical, laboratory, pulmonary function parameters and the prognosis of patients with DM-related ILD (DM-ILD) were analyzed. Immunohistochemical analysis was performed on lung tissues of DM-ILD patients to determine adrenomedullin expression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Adrenomedullin mRNA levels in PBMCs were significantly higher in DM patients than in IMNM patients and HCs (p\u00a0= 0.022 and p&amp;lt;0.001, respectively). Among DM patients, the levels were significantly higher in those with rapidly progressive ILD (RP-ILD) than in those with chronic ILD (p\u00a0= 0.002) or without ILD (p\u00a0&amp;lt; 0.001). The adrenomedullin mRNA levels in DM-ILD were positively correlated with serum ferritin (r\u00a0=0.507,\u00a0p\u00a0=0.002), lactate dehydrogenase (LDH) (r\u00a0=0.350,\u00a0p\u00a0=0.045), and lung visual analog scale (VAS) (r=0.392, p=0.021) and were negatively correlated with pulmonary function test parameters, including predicted forced vital capacity (FVC)% (r\u00a0= \u22120.523,\u00a0p\u00a0= 0.025), forced expiratory volume in 1 s (FEV1)% (r\u00a0= -0.539,\u00a0p\u00a0= 0.020), and diffusing capacity of carbon monoxide (DLco)% (r\u00a0= -0.495,\u00a0p\u00a0= 0.036). Immunohistochemical analysis of adrenomedullin confirmed higher expression in the alveolar epithelial cells and macrophages of DM patients with RP-ILD. Among the DM patients with ILD, the six decedents exhibited higher adrenomedullin levels than the 28 survivors (p\u2009= 0.042). The cumulative survival rate was significantly lower (62.5%\u00a0<jats:italic>vs<\/jats:italic>.\u00a0100%,\u00a0P\u2009=\u20090.005) in patients with an adrenomedullin level &amp;gt; 0.053 than in those with a level &amp;lt;0.053.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Adrenomedullin levels are upregulated in DM patients with RP-ILD and are associated with ILD severity and poor prognosis. Adrenomedullin may be a potential prognostic biomarker in DM patients with ILD, although need further investigation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.885142","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T05:18:17Z","timestamp":1654147097000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Adrenomedullin Expression Is Associated With the Severity and Poor Prognosis of Interstitial Lung Disease in Dermatomyositis Patients"],"prefix":"10.3389","volume":"13","author":[{"given":"Lifang","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuetong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and Management of Adult Inflammatory Myopathies","volume":"17","author":"Selva-O'Callaghan","year":"2018","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2018.41","article-title":"Classification of Myositis","volume":"14","author":"Lundberg","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.05.105","article-title":"Dermatomyositis: Diagnosis and Treatment","volume":"82","author":"Waldman","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1053\/sarh.2002.50012","article-title":"Interstitial Lung Disease in Polymyositis and Dermatomyositis: Clinical Course and Response to Treatment","volume":"32","author":"Schnabel","year":"2003","journal-title":"Semin Arthritis Rheum"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2174\/187153006779025775","article-title":"Recent Advances in the Treatment of Interstitial Lung Disease in Patients With Polymyositis\/Dermatomyositis","volume":"6","author":"Kameda","year":"2006","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00363","article-title":"Predictors and Mortality of Rapidly Progressive Interstitial Lung Disease in Patients With Idiopathic Inflammatory Myopathy: A Series of 474 Patients","volume":"7","author":"Li","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes102","article-title":"Anti-MDA5 Antibody, Ferritin and IL-18 are Useful for the Evaluation of Response to Treatment in Interstitial Lung Disease With Anti-MDA5 Antibody-Positive Dermatomyositis","volume":"51","author":"Gono","year":"2012","journal-title":"Rheumatol (Oxford)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu385","article-title":"Clinical and Laboratory Features of Fatal Rapidly Progressive Interstitial Lung Disease Associated With Juvenile Dermatomyositis","volume":"54","author":"Kobayashi","year":"2015","journal-title":"Rheumatol (Oxford)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq196","article-title":"Interleukin-18 is a Key Mediator in Dermatomyositis: Potential Contribution to Development of Interstitial Lung Disease","volume":"49","author":"Gono","year":"2010","journal-title":"Rheumatol (Oxford)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez571","article-title":"Lung Ultrasound B-Lines and Serum KL-6 Correlate With the Severity of Idiopathic Inflammatory Myositis-Associated Interstitial Lung Disease","volume":"59","author":"Wang","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13075-019-1835-9","article-title":"Serum KL-6 Levels Reflect the Severity of Interstitial Lung Disease Associated With Connective Tissue Disease","volume":"21","author":"Lee","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.1451","article-title":"Adrenomedullin: A Novel Hypotensive Peptide Isolated From Human Pheochromocytoma","volume":"192","author":"Kitamura","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"B13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1006\/bbrc.1995.1148","article-title":"Interleukin-1, Tumor Necrosis Factor and Lipopolysaccharide Additively Stimulate Production of Adrenomedullin in Vascular Smooth Muscle Cells","volume":"207","author":"Sugo","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1994.1827","article-title":"Endothelial Cells Actively Synthesize and Secrete Adrenomedullin","volume":"201","author":"Sugo","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1042\/cs0920059","article-title":"Elevated Plasma Levels of Human Adrenomedullin in Cardiovascular, Respiratory, Hepatic and Renal Disorders","volume":"92","author":"Cheung","year":"1997","journal-title":"Clin Sci (Lond)"},{"key":"B16","article-title":"Elevated Plasma Adrenomedullin and Vascular Manifestations in Patients With Systemic Sclerosis","volume":"34","author":"Mok","year":"2007","journal-title":"J Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel105","article-title":"Adrenomedullin\u2013a Potential Disease Activity Marker and Suppressor of Nephritis Activity in Systemic Lupus Erythematosus","volume":"45","author":"Mak","year":"2006","journal-title":"Rheumatol (Oxford)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.6.490d","article-title":"Raised Plasma Adrenomedullin Patients With Systemic Sclerosis Complicated by Pulmonary Hypertension","volume":"59","author":"Nanke","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"B19","article-title":"Increased Plasma and Joint Tissue Adrenomedullin Concentrations in Patients With Rheumatoid Arthritis Compared to Those With Osteoarthritis","volume":"30","author":"Chosa","year":"2003","journal-title":"J Rheumatol"},{"key":"B20","article-title":"Identification of Multiple, Oxygen-Stable HIF1 Alpha Isoforms, and Augmented Expression of Adrenomedullin in Rheumatoid Arthritis","volume":"31","author":"Green","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pupt.2019.01.006","article-title":"Adrenomedullin Mediates Pro-Angiogenic and Pro-Inflammatory Cytokines in Asthma and COPD","volume":"165","author":"Mandal","year":"2019","journal-title":"Pulm Pharmacol Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/art.40320","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop: Clinico-Sero-Pathological Classification of Immune-Mediated Necrotizing Myopathies. Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"B24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","article-title":"International Consensus Outcome Measures for Patients With Idiopathic Inflammatory Myopathies. Development and Initial Validation of Myositis Activity and Damage Indices in Patients With Adult Onset Disease","volume":"43","author":"Isenberg","year":"2004","journal-title":"Rheumatol (Oxford)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.2.ats3-00","article-title":"Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment. International Consensus Statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)","volume":"161","author":"William","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1164\/ajrccm.165.2","article-title":"American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This Joint Statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was Adopted by the ATS Board of Directors, June 2001 and by the ERS Executive Committee, June 2001","volume":"165","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9832430","article-title":"Adrenomedullin Regulates IL-1\u03b2 Gene Expression in F4\/80+ Macrophages During Synovial Inflammation","volume":"2017","author":"Takano","year":"2017","journal-title":"J Immunol Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9081068","article-title":"Adrenomedullin: A Novel Therapeutic for the Treatment of Inflammatory Bowel Disease","volume":"9","author":"Ashizuka","year":"2021","journal-title":"Biomedicines"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/art.38292","article-title":"Inhibition of Myogenic microRNAs 1, 133, and 206 by Inflammatory Cytokines Links Inflammation and Muscle Degeneration in Adult Inflammatory Myopathies","volume":"66","author":"Georgantas","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000744","article-title":"Cytokines and Inflammatory Mediators as Promising Markers of Polymyositis\/Dermatomyositis","volume":"32","author":"Cerezo","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.27.16730","article-title":"Production of Adrenomedullin in Macrophage Cell Line and Peritoneal Macrophage","volume":"273","author":"Kubo","year":"1998","journal-title":"J Biol Chem"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa034","article-title":"Clinical Significance of Radiological Patterns of HRCT and Their Association With Macrophage Activation in Dermatomyositis","volume":"59","author":"Zuo","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2832400","article-title":"FVC-NET: An Automated Diagnosis of Pulmonary Fibrosis Progression Prediction Using Honeycombing and Deep Learning","volume":"2022","author":"Yadav","year":"2022","journal-title":"Comput Intell Neurosci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.06.035","article-title":"Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative","volume":"161","author":"Hunninghake","year":"2022","journal-title":"Chest"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.885142\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T05:18:22Z","timestamp":1654147102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.885142\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":34,"alternative-id":["10.3389\/fimmu.2022.885142"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.885142","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]},"article-number":"885142"}}